These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32924956)

  • 1. Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study.
    Gomides A; Ferreira G; Kakehasi A; Lacerda M; Marques C; Mota L; Paiva E; Pileggi G; Provenza J; Reis-Neto E; Sampaio V; Xavier R; Pinheiro M
    JMIR Res Protoc; 2020 Oct; 9(10):e23532. PubMed ID: 32924956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.
    Marques C; Kakehasi AM; Gomides APM; Paiva EDS; Dos Reis Neto ET; Pileggi GCS; Provenza JR; Mota L; Xavier RM; Ferreira GA; Pinheiro MM
    JMIR Res Protoc; 2020 Dec; 9(12):e24357. PubMed ID: 33156812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
    Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM
    Adv Rheumatol; 2021 Oct; 61(1):60. PubMed ID: 34620246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy Outcomes and Child Development Effects of SARS-CoV-2 Infection (PROUDEST Trial): Protocol for a Multicenter, Prospective Cohort Study.
    Fernandes GM; Motta F; Sasaki LMP; Silva ÂPD; Miranda AM; Carvalho AO; Gomides APM; Soares AASM; Santos ACMD; Alves CO; Gomes CM; Siracusa CC; Araújo DA; Mendonça-Silva DL; Jesus JAL; Costa KN; Castro MEC; Kurizky PS; França PS; Tristão R; Pereira YR; Castro LCG; Zaconeta AM; Albuquerque CP; Mota LMHD
    JMIR Res Protoc; 2021 Apr; 10(4):e26477. PubMed ID: 33793409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.
    Mota GD; Marques CL; Ribeiro SL; Albuquerque C; Castro G; Fernandino D; Omura F; Ranzolin A; Resende G; Silva N; Souza M; Studart S; Xavier R; Yazbek M; Pinheiro MM
    Adv Rheumatol; 2023 Nov; 63(1):56. PubMed ID: 38031143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study.
    Kurizky P; Nóbrega OT; Soares AASM; Aires RB; Albuquerque CP; Nicola AM; Albuquerque P; Teixeira-Carvalho A; Naves LA; Fontes W; Luz IS; Felicori L; Gomides APM; Mendonça-Silva DL; Espindola LS; Martins-Filho OA; de Lima SMB; Mota LMH; Gomes CM
    JMIR Res Protoc; 2021 Mar; 10(3):e24211. PubMed ID: 33661132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory Effects of Physical Activity Levels on Immune Responses and General Clinical Functions in Adult Patients with Mild to Moderate SARS-CoV-2 Infections-A Protocol for an Observational Prospective Follow-Up Investigation: Fit-COVID-19 Study.
    Lira FS; Pereira T; Guerra Minuzzi L; Figueiredo C; Olean-Oliveira T; Figueira Freire APC; Coelho-E-Silva MJ; Caseiro A; Thomatieli-Santos RV; Dos Santos VR; Gobbo LA; Seelaender M; Krüger K; Pinho RA; Rosa-Neto JC; de Alencar Silva BS
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948858
    [No Abstract]   [Full Text] [Related]  

  • 8. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis.
    Landsteiner de Sampaio Amêndola I; Aires Pinheiro J; Póvoa P; Cés de Souza Dantas V; Serafim RB
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.
    Calderaro DC; Kahlow BS; Munhoz GA; Dias SEB; Lopes JVZ; Borges AR; Mariz HA; Gomes KWP; Valadares LDA; Araújo NC; Ribeiro SLE; Kakehasi AM; Reis APMG; Marques C; Reis-Neto ET; Paiva EDS; Pileggi GS; Ferreira GA; Provenza JR; Mota LMH; Xavier RM; Teodoro MLM; Pinheiro MM;
    JMIR Res Protoc; 2021 Apr; 10(4):e24617. PubMed ID: 33735094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
    Boekel L; Atiqi S; Leeuw M; Hooijberg F; Besten YR; Wartena R; Steenhuis M; Vogelzang E; Webers C; Boonen A; Gerritsen M; Lems WF; Tas SW; van Vollenhoven RF; Voskuyl AE; van der Horst-Bruinsma I; Nurmohamed M; Rispens T; Wolbink G
    Lancet Rheumatol; 2023 Jul; 5(7):e375-e385. PubMed ID: 37398978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the outcomes of SARS-CoV-2 infection in children and young people followed at Portuguese pediatric rheumatology clinics.
    Melo AT; Bernardo M; Pinheiro F; Rodrigues M; Torres R; Mourão AF; Carvalho S; Nascimento J; Sousa S; Santos MJ; Soares C; Cabral M; Marques RC; Reis PC; Ramos FO
    ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):205-209. PubMed ID: 36056926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
    Pinheiro MM; Pileggi GS; Kakehasi AM; Gomides Reis APM; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa E; Borba EF; Egypto Brito DCS; Calderaro DC; Pinto Duarte ÂLB; Espírito Santo RC; Fernandes PR; Guimarães MP; Poti Gomes KW; Faustino Ilana GG; Klumb EM; Marques CDL; Guedes de Melo AK; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Rocha LF; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Ferreira GA
    Clin Exp Rheumatol; 2022 Jul; 40(7):1258-1266. PubMed ID: 34251312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2.
    Musca SC
    Front Med (Lausanne); 2020; 7():490. PubMed ID: 32903552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center.
    Sözeri B; Demir F; Kalın S; Hasbal Akkuş C; Salı E; Çakır D
    Arch Rheumatol; 2021 Sep; 36(3):381-388. PubMed ID: 34870170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatological aspects of pathogenesis and treatment of COVID-19 infection.
    Kalinova D; Rashkov R
    Reumatologia; 2020; 58(4):231-235. PubMed ID: 32921830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie
    Gamboa-Alonso CM; Figueroa-Parra G; Galarza-Delgado DA
    Ann Rheum Dis; 2021 Jan; 80(1):e7. PubMed ID: 32571868
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune-Mediated Mechanisms in Patients Testing Positive for SARS-CoV-2: Protocol for a Multianalysis Study.
    Ietto G; Mortara L; Dalla Gasperina D; Iovino D; Azzi L; Baj A; Ageno W; Genoni AP; Acquati F; Gallazzi M; Spina G; Coco G; Pierin F; Noonan D; Vigezzi A; Monti E; Iori V; Masci F; Franchi C; Di Saverio S; Carcano G
    JMIR Res Protoc; 2022 Jan; 11(1):e29892. PubMed ID: 34854818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City.
    Lozano-Cruz OA; Jiménez JV; Olivas-Martinez A; Ortiz-Brizuela E; Cárdenas-Fragoso JL; Azamar-Llamas D; Rodríguez-Rodríguez S; Oseguera-Moguel JC; Dorantes-García J; Barrón-Magdaleno C; Cázares-Diazleal AC; Román-Montes CM; Tamez-Torres KM; Martínez-Guerra BA; Gulias-Herrero A; González-Lara MF; Ponce-de-León-Garduño A; Kershenobich-Stalnikowitz D; Sifuentes-Osornio J
    Front Pharmacol; 2021; 12():668678. PubMed ID: 34149420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.